🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 16 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/01/2014 14,51 15,30 14,48 15,30 +6,99% 5,69% 1.794.400
29/01/2014 13,50 14,52 13,13 14,30 +4,69% 10,33% 2.669.800
28/01/2014 12,17 13,80 12,10 13,66 +13,55% 13,97% 1.271.600
27/01/2014 11,38 12,80 11,20 12,03 +2,65% 14,07% 1.053.400
24/01/2014 11,50 12,09 10,80 11,72 +0,17% 11,22% 844.700
23/01/2014 11,85 11,95 11,37 11,70 -2,42% 4,89% 477.700
22/01/2014 11,79 12,48 11,79 11,99 +0,08% 5,85% 533.000
21/01/2014 12,40 12,49 11,73 11,98 -2,68% 6,11% 818.200
17/01/2014 12,56 12,74 12,25 12,31 -2,76% 3,87% 371.500
16/01/2014 13,00 13,15 12,26 12,66 -2,62% 6,85% 663.100
15/01/2014 12,52 13,39 12,09 13,00 +1,25% 10,38% 884.100
14/01/2014 12,50 12,96 12,00 12,84 +4,22% 7,64% 1.011.000
13/01/2014 12,66 13,87 11,61 12,32 +1,82% 17,85% 2.114.600
10/01/2014 11,54 12,36 11,01 12,10 +5,22% 11,70% 1.420.200
09/01/2014 10,88 11,57 10,82 11,50 +7,78% 6,89% 1.666.200
08/01/2014 9,95 10,75 9,78 10,67 +6,59% 9,75% 759.200
07/01/2014 9,83 10,20 9,76 10,01 +0,91% 4,48% 398.700
06/01/2014 10,09 10,44 9,87 9,92 -2,46% 5,65% 695.600
03/01/2014 10,35 10,36 9,94 10,17 -1,36% 4,01% 466.100
02/01/2014 10,75 10,75 9,95 10,31 -4,98% 7,44% 522.900
31/12/2013 10,68 10,88 10,65 10,85 +1,40% 2,15% 243.200
30/12/2013 10,78 10,88 10,60 10,70 -2,01% 2,60% 329.000
27/12/2013 11,05 11,05 10,52 10,92 -1,36% 4,80% 450.500
26/12/2013 10,76 11,12 10,58 11,07 +2,12% 5,02% 492.500
24/12/2013 10,77 10,89 10,15 10,84 +1,21% 6,87% 357.700
23/12/2013 10,25 10,72 10,11 10,71 +7,85% 5,95% 1.279.700
20/12/2013 9,45 10,39 9,33 9,93 +5,75% 11,22% 1.355.800
19/12/2013 9,62 9,65 9,21 9,39 +2,74% 4,57% 933.300
18/12/2013 9,01 9,49 8,60 9,14 +4,46% 9,88% 2.803.000
17/12/2013 8,72 9,09 8,55 8,75 +0,11% 6,19% 634.600